featured
Cost-Effectiveness of Sacral Neuromodulation vs OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Journal of Urology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cost Effectiveness of Sacral Neuromodulation Versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: Results of the ROSETTA Randomized Trial
J Urol 2019 Nov 18;[EPub Ahead of Print], HS Harvie, CL Amundsen, SJ Neuwahl, AA Honeycutt, ES Lukacz, VW Sung, RG Rogers, D Ellington, CA Ferrando, CJ Chermansky, D Mazloomdoost, S ThomasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.